NCT06388538

Brief Summary

Since it is still debated whether 2b acute diverticulitis (AD), according to the World Society of Emergency Surgery (WSES) classification, should be initially treated surgically or conservatively, the COLD2B study has been launched to compare the clinical results of both therapeutic regimens in a multi-institutional cohort of prospectively enrolled patients. The primary aim of the COLD2B (Conservative vs surgical (either Open or Laparoscopic) approach in the emergency management of acute Diverticulitis WSES 2B) study is to develop a model able to predict the length of hospitalization, comparing the management of WSES 2b AD in the emergency setting (conservative versus surgical approach) (primary endpoint of the first arm of the study). Moreover, the two groups will be compared regarding mortality and morbidity (secondary end-point). The second arm of the study will consider the population undergoing surgery, develop a model able to predict the length of hospitalization, and compare the open vs laparoscopic approach (primary end-point), and mortality, morbidity, and surgical outcome indices (secondary end-point).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 29, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

11 months

First QC Date

April 20, 2024

Last Update Submit

April 27, 2024

Conditions

Keywords

COLD2bacute diverticulitis stage 2B WSESsigmoid acute diverticulitisleft-side colonic acute diverticulitis

Outcome Measures

Primary Outcomes (1)

  • Length of hospital stay in the overall population

    To develop a predictive model for the length of hospital stay (measured in days) taking into account the treatment received in the overall population

    1 year

Secondary Outcomes (3)

  • Morbidity rate for both arms

    1 year

  • Mortality rate for both arms

    1 year

  • Surgical complications rate

    1 year

Study Arms (1)

Patients with WSES stage 2b acute diverticulitis

Patients with WSES stage 2b acute diverticulitis on the left or sigmoid colon acutely presenting to the emergency departments of the participating centers

Other: Conservative treatment (non-operative treatment)Other: Surgical treatment (operative treatment)

Interventions

Conservative treatment consists of medical therapy (see fluid, anti-pain drugs and antibiotics, except for radiologic drainage)

Patients with WSES stage 2b acute diverticulitis

Surgical treatment (operative treatment) is explained as follows: 1. Open surgery management, i.e. traditional open surgery approach with any kind of technique: either reconstructive (with or without ileal/colonic stoma protection) or non-reconstructive (see Hartman procedure) 2. Laparoscopic approach, i.e. emergency laparoscopic resection with the characteristics mentioned above

Patients with WSES stage 2b acute diverticulitis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients affected by WSES 2b acute diverticulitis actively present at participating hospitals

You may qualify if:

  • Patients of both sexes, ≥ 18 years old.
  • Patients with abdominal CT scan diagnosis of colonic Acute Diverticulitis classifiable as WSES 2B, i.e..
  • thickening and other phlegmon signs of the left-sided colonic wall (mostly sigmoid) associated with the inflammatory involvement of the surrounding tissues, plus
  • presence of air bubbles distant more than 5 cm from the primary colonic inflammatory localization, plus
  • absence of conspicuous free fluid collection or pelvic abscess.
  • Patients fit for surgery.
  • Patients with colonic diverticulitis on postoperative histological examination.

You may not qualify if:

  • Right-sided or transverse diverticulitis
  • Concomitant bowel abscess, perforation, or fistula
  • Radiological drainage
  • Elective procedures.
  • Pregnancy or lactation
  • Patients of both sexes, younger than 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica (DiMePRe-J), Universita' di Bari

Bari, Italy

Location

Department of Emergency and Acceptance, Emergency Surgery Unit, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

Florence, 50134, Italy

Location

Department of Medicine, Surgery and Health Sciences, University of Trieste

Trieste, Italy

Location

Department of General Surgery, PO di Vittorio Veneto (TV), ULSS2 Marca Trevigiana

Vittorio Veneto, Italy

Location

Related Publications (2)

  • undefined

    BACKGROUND
  • Giordano A, Mastronardi M, Montori G, Anania G, Bergamini C. A focus of therapeutic strategies in acute diverticulitis with distant free air: a systematic review. Updates Surg. 2025 Dec 9. doi: 10.1007/s13304-025-02467-9. Online ahead of print.

Related Links

MeSH Terms

Interventions

Conservative TreatmentSurgical Procedures, Operative

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

Carlo Bergamini Carlo Bergamini, M.D.

CONTACT

Alessio Biagio Giordano Alessio Giordano, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 20, 2024

First Posted

April 29, 2024

Study Start

June 1, 2024

Primary Completion

May 1, 2025

Study Completion

June 1, 2025

Last Updated

April 30, 2024

Record last verified: 2024-04

Locations